» Articles » PMID: 10331349

Selective Review of Key Perioperative Renal-electrolyte Disturbances in Chronic Renal Failure Patients

Overview
Journal Chest
Publisher Elsevier
Specialty Pulmonary Medicine
Date 1999 May 20
PMID 10331349
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

The medical care of chronic renal failure patients is often complicated by the comorbid conditions of hypertension and coronary artery disease in the perioperative period. The limitations on solute and water excretion imposed by renal dysfunction increase the susceptibility of this population to both salt deficit and surfeit, as well as hyponatremia and hypernatremia perioperatively. Accurate assessment and successful treatment of these complications in renal failure patients require understanding of the concept of electrolyte-free water, proper utilization of diuretics, and calculated prescription of fluid therapy. The presence of hyperkalemia in the adapted renal failure patient generally indicates a severe reduction in glomerular filtration, such that nonrenal hypokalemic treatments are imperative. IV calcium-based therapy and infusion of insulin with glucose represent the mainstays of immediate therapy, and sodium bicarbonate therapy should be given only when severe acidemia is present. Perioperative aggravation of preexistent hypertension is common. Rebound hypertension attributable to injudicious adjustment of the medical regimen should be diligently searched for first, before any new therapies are recommended. Relief of pain or anxiety may be all that is necessary. Briefly acting calcium channel blocker therapy should not be employed in these cases, and smooth IV control by a variety of agents is preferable, the choice of the agent contingent on the clinical scenario.

Citing Articles

The effects of the dialysis on the white matter tracts in patients with end-stage renal disease using differential tractography study.

Park B, Choi B, Heo C, Lee Y, Park S, Kim Y Sci Rep. 2023; 13(1):20064.

PMID: 37973892 PMC: 10654401. DOI: 10.1038/s41598-023-47533-7.


Study on the mechanism of Shenkang injection in the treatment of chronic renal failure based on the strategy of "Network pharmacology-Molecular docking-Key target validation".

Zhou L, Wang X, Sun Z, Bao X, Xue L, Xu Z PLoS One. 2023; 18(10):e0291621.

PMID: 37796994 PMC: 10553805. DOI: 10.1371/journal.pone.0291621.


Association Between Preoperative Hemodialysis Timing and Postoperative Mortality in Patients With End-stage Kidney Disease.

Fielding-Singh V, Vanneman M, Grogan T, Neelankavil J, Winkelmayer W, Chang T JAMA. 2022; 328(18):1837-1848.

PMID: 36326747 PMC: 9634601. DOI: 10.1001/jama.2022.19626.


Effects of the Type of Intraoperative Fluid in Living Donor Kidney Transplantation: A Single-Center Retrospective Cohort Study.

Jung S, Kim J, Lee J, Choi S, Joo H, Koo B Yonsei Med J. 2022; 63(4):380-388.

PMID: 35352890 PMC: 8965431. DOI: 10.3349/ymj.2022.63.4.380.


Timing of intraoperative crystalloid infusion may decrease total volume of infusate without affecting early graft function in live related renal transplant surgery: A randomized, surgeon-blinded clinical study.

Singh A, Ramachandran R, Chandralekha C, Trikha A, Ray B, Bansal V Indian J Urol. 2022; 38(1):53-61.

PMID: 35136296 PMC: 8796753. DOI: 10.4103/iju.iju_239_21.